TyraTech Head Lice Shampoo Vamousse Receives US FDA Listing

Mon, 20th Jan 2014 08:55

LONDON (Alliance News) - TyraTech Inc. said Monday that its head-lice shampoo Vamousse is now listed with the US Food and Drug Administration and will be available for sale in the US from the end of the first quarter of 2014.

Last Tuesda,y the biotechnology company said Vamousse would be sold in Walmart Stores in the US from the end of March. The company said the head-lice control market in the US is worth around USD150 million and hopes its Vamousse product will make an impact.

Shares in TyraTech were trading up 9.1% at 6.00 pence Monday morning.

By Hana Stewart-Smith; hanassmith@alliancenews.com; @HanaSSAllNews

Related Shares

More News

16 Jul 2014 17:09

TyraTech does head lice deals with Boots and Superdrug

Life science group TyraTech announced deals with British chemist chains for its head lice treatment and raised £3.5m in a share placing. TyraTech, w...

8 Apr 2014 17:18

DIRECTOR DEALINGS: TyraTech Non-Executive Chairman Sells, Buys Shares

LONDON (Alliance News) - Natural life sciences company TyraTech Inc said Tuesday that Chairman Alan Reade and his wife sold 202,500 shares at a price ...

9 Feb 2014 12:46

Sunday share tips: Vodafone, Rockhopper, TyraTech

Hold on to shares of Vodafone once the sale of its stake in Verizon is completed, the Sunday Telegraph's Questor column said. Vodafone will pay 104p a...

20 Jan 2014 13:13

UK MIDDAY BRIEFING: Royal Dutch Shell In Australian Asset Sell-Off

LONDON (Alliance News) - Royal Dutch Shell Monday said it will sell its interests in the Australian Wheatstone gas projects in a USD1.14 billion deal,...

20 Jan 2014 11:21

UK WINNERS & LOSERS: UK Banks Hit By Deutsche Bank Losses

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Monday.-------FTSE 100 - LOSERS...

Latest Share Chat